BENITEC BIOPHARMA INC (BNTC) Institutional Ownership Changes & 13F Activity
BENITEC BIOPHARMA INC (BNTC). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Ameriprise Financial Inc, Millennium Management Llc, Longaeva Partners L.P., Citadel Advisors Llc, and Schonfeld Strategic Advisors Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Sell | -90,256 | -52.6% | 81,466 | $1.09M | Q2 2026 | Sep 02, 2026 |
| California State Teachers Retirement System | Sell | -794 | -74.5% | 272 | $3.64K | Q2 2026 | Aug 24, 2026 |
| Nantahala Capital Management, Llc | Buy | +50,000 | +3.5% | 1,488,371 | $19.91M | Q2 2026 | Aug 19, 2026 |
| Ameriprise Financial Inc | Buy | +401,245 | — | 401,245 | $5.37M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Buy | +269,235 | +41.3% | 921,299 | $12.33M | Q2 2026 | Aug 14, 2026 |
| Longaeva Partners L.P. | Sell | -110,126 | -88.1% | 14,874 | $199.01K | Q2 2026 | Aug 14, 2026 |
| Schonfeld Strategic Advisors Llc | Buy | +82,178 | +53.6% | 235,357 | $3.15M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Sell | -37,435 | -17.4% | 178,041 | $2.38M | Q2 2026 | Aug 14, 2026 |
| Mirae Asset Global Etfs Holdings Ltd. | Buy | +36,023 | +396.6% | 45,106 | $603.52K | Q2 2026 | Aug 14, 2026 |
| Adar1 Capital Management, Llc | Buy | +22,500 | +128.6% | 40,000 | $535.20K | Q2 2026 | Aug 14, 2026 |
| Aqr Capital Management Llc | Buy | +22,481 | — | 22,481 | $300.80K | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Buy | +18,528 | — | 18,528 | $248.00K | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +10,985 | — | 10,985 | $146.98K | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Buy | +10,897 | +154.7% | 17,942 | $240.06K | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Buy | +9,440 | +15.4% | 70,851 | $947.99K | Q2 2026 | Aug 14, 2026 |
| Metlife Investment Management, Llc | Buy | +6,027 | +64.1% | 15,424 | $206.37K | Q2 2026 | Aug 14, 2026 |
| Atom Investors Lp | Sell | -3,872 | -7.4% | 48,591 | $650.15K | Q2 2026 | Aug 14, 2026 |
| Balyasny Asset Management L.P. | Sell | -3,332 | -0.5% | 650,503 | $8.70M | Q2 2026 | Aug 14, 2026 |
| Jones Financial Companies Lllp | Buy | +1,770 | +445.8% | 2,167 | $26.81K | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Sell | -1,405 | -8.1% | 15,971 | $213.69K | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Sell | -420 | -11.0% | 3,415 | $45.69K | Q2 2026 | Aug 14, 2026 |
| Legal & General Group Plc | Buy | +385 | +22.1% | 2,131 | $28.51K | Q2 2026 | Aug 14, 2026 |
| Royal Bank Of Canada | Buy | +279 | +78.2% | 636 | $9.00K | Q2 2026 | Aug 14, 2026 |
| Silverarc Capital Management, Llc | Sell | -37,899 | -5.3% | 679,826 | $9.10M | Q2 2026 | Aug 13, 2026 |
| Vanguard Portfolio Management Llc | Buy | +28,764 | +25.1% | 143,510 | $1.92M | Q2 2026 | Aug 13, 2026 |
| Myda Advisors Llc | Buy | +25,000 | +11.1% | 250,000 | $3.35M | Q2 2026 | Aug 13, 2026 |
| Vanguard Capital Management Llc | Buy | +22,977 | +2.5% | 954,533 | $12.77M | Q2 2026 | Aug 13, 2026 |
| Northern Trust Corp | Buy | +21,110 | +13.4% | 178,434 | $2.39M | Q2 2026 | Aug 13, 2026 |
| Martingale Asset Management L P | Buy | +16,150 | — | 16,150 | $216.09K | Q2 2026 | Aug 13, 2026 |
| Vanguard Fiduciary Trust Co | Sell | -10,758 | -6.3% | 160,995 | $2.15M | Q2 2026 | Aug 13, 2026 |
Frequently asked questions about BNTC activity
Which institutional owners are buying BNTC?
Institutional owners buying BNTC include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in BNTC activity?
"Buy" means an investor increased their reported position in BNTC compared to the prior reporting period. This reflects growing exposure to BENITEC BIOPHARMA INC (BNTC) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in BNTC increasing?
Institutional interest in BNTC can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related BNTC Institutional Insights
- BNTC Overview
- BNTC 13F Institutional Holders
- BNTC Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- BNTC Insider Trading & SEC Form 4 Activity
- BNTC Articles
- Top Institutional Investor Stock Rankings